These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 34275790)

  • 1. Profiling of inflammatory biomarkers in mild to critically ill severe acute respiratory syndrome corona virus-19 (SARS Covid-19) patients from Karachi, Pakistan.
    Alam JM; Asghar SS; Ali H; Mahmood SR; Ansari MA
    Pak J Pharm Sci; 2021 Jan; 34(1(Special)):429-433. PubMed ID: 34275790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of inflammatory biomarkers in patients with COVID-19 infections: Bahrain experience.
    Farid E; Sridharan K; Alsegai OA; Khawaja SA; Mansoor EJ; Teraifi NA; Qahtani MA; Salman JA
    Biomark Med; 2021 Jun; 15(8):541-549. PubMed ID: 33988463
    [No Abstract]   [Full Text] [Related]  

  • 3. REPORT- Varying pattern of blood gases, ferritin, procalcitonin, C-Reactive protein, interleukin 6 and lactate dehydrogenase in Covid-19 patients suffering from diverse Co-Morbid, suspected cytokine storm and periodic effects of antiviral and steroidal treatments.
    Mahmood Alam J; Asghar SS; Ali H; Mahmood SR; Ansari MA
    Pak J Pharm Sci; 2021 Nov; 34(6):2265-2271. PubMed ID: 35034890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis of SARS-CoV-2 infection in the setting of the cytokine release syndrome.
    Azar MM; Shin JJ; Kang I; Landry M
    Expert Rev Mol Diagn; 2020 Nov; 20(11):1087-1097. PubMed ID: 32990479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased levels of plasma cytokines and correlations to organ failure and 30-day mortality in critically ill Covid-19 patients.
    Bülow Anderberg S; Luther T; Berglund M; Larsson R; Rubertsson S; Lipcsey M; Larsson A; Frithiof R; Hultström M
    Cytokine; 2021 Feb; 138():155389. PubMed ID: 33348065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal correlation of biomarkers of cardiac injury, inflammation, and coagulation to outcome in hospitalized COVID-19 patients.
    Li C; Jiang J; Wang F; Zhou N; Veronese G; Moslehi JJ; Ammirati E; Wang DW
    J Mol Cell Cardiol; 2020 Oct; 147():74-87. PubMed ID: 32827510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors.
    Han H; Ma Q; Li C; Liu R; Zhao L; Wang W; Zhang P; Liu X; Gao G; Liu F; Jiang Y; Cheng X; Zhu C; Xia Y
    Emerg Microbes Infect; 2020 Dec; 9(1):1123-1130. PubMed ID: 32475230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma biomarker profiling of PIMS-TS, COVID-19 and SARS-CoV2 seropositive children - a cross-sectional observational study from southern India.
    Venkataraman A; Kumar NP; Hanna LE; Putlibai S; Karthick M; Rajamanikam A; Sadasivam K; Sundaram B; Babu S
    EBioMedicine; 2021 Apr; 66():103317. PubMed ID: 33813138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal Cytokine Profile in Patients With Mild to Critical COVID-19.
    Ling L; Chen Z; Lui G; Wong CK; Wong WT; Ng RWY; Tso EYK; Fung KSC; Chan V; Yeung ACM; Hui DSC; Chan PKS
    Front Immunol; 2021; 12():763292. PubMed ID: 34938289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viral RNA load in plasma is associated with critical illness and a dysregulated host response in COVID-19.
    Bermejo-Martin JF; González-Rivera M; Almansa R; Micheloud D; Tedim AP; Domínguez-Gil M; Resino S; Martín-Fernández M; Ryan Murua P; Pérez-García F; Tamayo L; Lopez-Izquierdo R; Bustamante E; Aldecoa C; Gómez JM; Rico-Feijoo J; Orduña A; Méndez R; Fernández Natal I; Megías G; González-Estecha M; Carriedo D; Doncel C; Jorge N; Ortega A; de la Fuente A; Del Campo F; Fernández-Ratero JA; Trapiello W; González-Jiménez P; Ruiz G; Kelvin AA; Ostadgavahi AT; Oneizat R; Ruiz LM; Miguéns I; Gargallo E; Muñoz I; Pelegrin S; Martín S; García Olivares P; Cedeño JA; Ruiz Albi T; Puertas C; Berezo JÁ; Renedo G; Herrán R; Bustamante-Munguira J; Enríquez P; Cicuendez R; Blanco J; Abadia J; Gómez Barquero J; Mamolar N; Blanca-López N; Valdivia LJ; Fernández Caso B; Mantecón MÁ; Motos A; Fernandez-Barat L; Ferrer R; Barbé F; Torres A; Menéndez R; Eiros JM; Kelvin DJ
    Crit Care; 2020 Dec; 24(1):691. PubMed ID: 33317616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic inflammation as fuel for acute liver injury in COVID-19.
    Effenberger M; Grander C; Grabherr F; Griesmacher A; Ploner T; Hartig F; Bellmann-Weiler R; Joannidis M; Zoller H; Weiss G; Adolph TE; Tilg H
    Dig Liver Dis; 2021 Feb; 53(2):158-165. PubMed ID: 32873520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory markers in gynecologic oncology patients hospitalized with COVID-19 infection.
    Smith M; Lara OD; O'Cearbhaill R; Knisely A; McEachron J; Gabor L; Carr C; Blank S; Prasad-Hayes M; Frey M; Jee J; Fehniger J; Wang Y; Lee YC; Isani S; Wright JD; Pothuri B
    Gynecol Oncol; 2020 Dec; 159(3):618-622. PubMed ID: 33019984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IP-10 and MCP-1 as biomarkers associated with disease severity of COVID-19.
    Chen Y; Wang J; Liu C; Su L; Zhang D; Fan J; Yang Y; Xiao M; Xie J; Xu Y; Li Y; Zhang S
    Mol Med; 2020 Oct; 26(1):97. PubMed ID: 33121429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin A Plasma Levels in COVID-19 Patients: A Prospective Multicenter Study and Hypothesis.
    Tepasse PR; Vollenberg R; Fobker M; Kabar I; Schmidt H; Meier JA; Nowacki T; Hüsing-Kabar A
    Nutrients; 2021 Jun; 13(7):. PubMed ID: 34202697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarkers of cytokine storm as red flags for severe and fatal COVID-19 cases: A living systematic review and meta-analysis.
    Melo AKG; Milby KM; Caparroz ALMA; Pinto ACPN; Santos RRP; Rocha AP; Ferreira GA; Souza VA; Valadares LDA; Vieira RMRA; Pileggi GS; Trevisani VFM
    PLoS One; 2021; 16(6):e0253894. PubMed ID: 34185801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysregulated plasma lipid mediator profiles in critically ill COVID-19 patients.
    Palmas F; Clarke J; Colas RA; Gomez EA; Keogh A; Boylan M; McEvoy N; McElvaney OJ; McElvaney O; Alalqam R; McElvaney NG; Curley GF; Dalli J
    PLoS One; 2021; 16(8):e0256226. PubMed ID: 34437568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics and prognostic factors of disease severity in patients with COVID-19: The Beijing experience.
    Sun Y; Dong Y; Wang L; Xie H; Li B; Chang C; Wang FS
    J Autoimmun; 2020 Aug; 112():102473. PubMed ID: 32439209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A specific low-density neutrophil population correlates with hypercoagulation and disease severity in hospitalized COVID-19 patients.
    Morrissey SM; Geller AE; Hu X; Tieri D; Ding C; Klaes CK; Cooke EA; Woeste MR; Martin ZC; Chen O; Bush SE; Zhang HG; Cavallazzi R; Clifford SP; Chen J; Ghare S; Barve SS; Cai L; Kong M; Rouchka EC; McLeish KR; Uriarte SM; Watson CT; Huang J; Yan J
    JCI Insight; 2021 May; 6(9):. PubMed ID: 33986193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement C5a and Clinical Markers as Predictors of COVID-19 Disease Severity and Mortality in a Multi-Ethnic Population.
    Cyprian FS; Suleman M; Abdelhafez I; Doudin A; Masud Danjuma M; Mir FA; Parray A; Yousaf Z; Siddiqui MYA; Abdelmajid A; Mulhim M; Al-Shokri S; Abukhattab M; Shaheen R; Elkord E; Al-Khal AL; Elzouki AN; Girardi G
    Front Immunol; 2021; 12():707159. PubMed ID: 34966381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarkers for the prediction of venous thromboembolism in critically ill COVID-19 patients.
    Dujardin RWG; Hilderink BN; Haksteen WE; Middeldorp S; Vlaar APJ; Thachil J; Müller MCA; Juffermans NP
    Thromb Res; 2020 Dec; 196():308-312. PubMed ID: 32977128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.